Antipsychotic-Induced Extrapyramidal Symptoms

A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS

1970 • 3,213 citations

Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine

1992 • 1,420 citations

Psychopharmacology : a generation of progress

1978 • 1,168 citations

A Survey of Drug-Induced Extrapyramidal Reactions

1961 • 756 citations

Tardive Dyskinesia

1982 • 660 citations

Memory and cognitive function in man

1977 • 624 citations

Tardive dystonia

1982 • 605 citations

Why Do Schizophrenic Patients Refuse to Take Their Drugs?

1974 • 584 citations

The molecular basis of muscarinic receptor diversity

1989 • 544 citations

'Akinetic Depression' in Schizophrenia

1978 • 388 citations

Update on the Clinical Efficacy and Side Effects of Clozapine

1991 • 298 citations

Botulinum toxin injections for cervical dystonia

1990 • 285 citations

CHOLINERGIC ‘BLOCKADE’ AS A MODEL FOR CHOLINERGIC DEPLETION

1988 • 258 citations

Akathisia Variants and Tardive Dyskinesia

1985 • 257 citations

Clinical Characteristics of Akathisia

1983 • 252 citations

Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association

1993 • 232 citations

Acute dystonia induced by neuroleptic drugs

1986 • 220 citations

Integrating incidence and prevalence of tardive dyskinesia.

1986 • 209 citations

Withdrawal syndromes associated with antipsychotic drugs

1978 • 192 citations

Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients

1982 • 175 citations

Prospective Study of Tardive Dyskinesia Incidence in the Elderly

1991 • 172 citations

Positron Emission Tomography Studies on D2 and 5-HT2 Receptor Binding in Risperidone-Treated Schizophrenic Patients

1995 • 156 citations

Adverse effects of anticholinergic medication on positive schizophrenic symptoms

1983 • 152 citations

Psychiatric aspects of neurological disease

1975 • 151 citations

Behavioral toxicity of antipsychotic drugs.

1987 • 150 citations

A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics

1975 • 142 citations

Drug-induced dystonia

1975 • 142 citations

Propranolol in the treatment of neuroleptic-induced akathisia

1984 • 117 citations

Evaluating the Long-Term Need for Antiparkinson Drugs by Chronic Schizophrenics

1972 • 113 citations

Are Prophylactic Antiparkinson Drugs Necessary?

1978 • 112 citations

Clinical Characteristics and Predisposing Factors in Acute Drug-Induced Akathisia

1994 • 107 citations

Botulinum Toxin Treatment of Spasmodic Torticollis

1992 • 106 citations

A Controlled Assessment of Propranolol in the Treatment of Neuroleptic-Induced Akathisia

1986 • 104 citations

A 5-year prospective longitudinal study of tardive dyskinesia: factors predicting appearance of new cases.

1988 • 101 citations

Anticholinergic drug abuse: a common problem?

1984 • 93 citations

Pharmacotherapy of Impaired Affect in Recovering Schizophrenic Patients

1995 • 84 citations

Prevalence of tardive dystonia

1986 • 84 citations

The clinical phenomenon of akathisia.

1986 • 80 citations

Efficacy of anticholinergic prophylaxis for neuroleptic-induced acute dystonia

1988 • 80 citations

Dopaminergic Activity of the Antimuscarinic Antiparkinsonian Agents

1989 • 75 citations

Adjunctive Medication in the Maintenance Treatment of Schizophrenia and its Conceptual Implications

1993 • 73 citations

A Study of Benzhexol Abuse

1984 • 72 citations

The Abrupt Withdrawal of Antiparkinsonian Drugs in Schizophrenic Patients

1974 • 72 citations

Tardive dystonia in a psychiatric hospital.

1987 • 71 citations

Adverse effects of antiparkinson drug withdrawal

1981 • 70 citations

Sodium vaiproate and biperiden in neuroleptic‐induced akathisia, parkinsonism and hyperkinesia

1983 • 66 citations

The Withdrawal of Benztropine Mesylate in Chronic Schizophrenic Patients

1983 • 64 citations

Depot neuroleptics: a comparative review of standard, intermediate, and low-dose regimens.

1986 • 64 citations

Withdrawal of Antiparkinson Drugs

1971 • 63 citations

Abuse of the antiparkinson drugs: a review of the literature.

1980 • 62 citations

Clozapine treatment of psychosis in patients with tardive dystonia: Report of three cases

1994 • 62 citations

Prediction of Neuroleptic-Induced Dystonia

1987 • 61 citations

Drug-induced dystonia in young and elderly patients

1988 • 58 citations

PERSISTENT MUSCULAR RESTLESSNESS AFTER PHENOTHIAZINE TREATMENT: REPORT OF 3 CASES

1960 • 56 citations

Review of Adverse Effects of Psychotropic Drugs.

1995 • 53 citations

Tardive dyskinesia and anticholinergic drugs

1983 • 53 citations

Anticholinergic Prophylaxis of Acute Haloperidol-Induced Acute Dystonic Reactions

1987 • 52 citations

How to distinguish between the neuroleptic-induced deficit syndrome, depression and disease-related negative symptoms in schizophrenia

1995 • 52 citations

The need for continuous use of antiparkinsonian medication with chronic schizophrenic patients receiving long-term neuroleptic therapy

1981 • 47 citations

Assessment of drugs in schizophrenia. Asessment of drug‐induced extrapyramidal reactions and of drugs given for their control.

1976 • 44 citations

Prevention of acute dystonic reactions in patients beginning high- potency neuroleptics [published erratum appears in Am J Psychiatry 1986 Sep;143(9):1204]

1986 • 42 citations

Selective inactivation of muscarinic receptor subtypes

1994 • 42 citations

Prevalence of the rabbit syndrome

1986 • 41 citations

Comment on the WHO Consensus Statement

1990 • 40 citations

Prevalence and Treatment of Drug-Induced Extrapyramidal Symptoms

1978 • 39 citations

The effect of benztropine on haloperidol-induced dystonia, clinical efficacy and pharmacokinetics: a prospective, double-blind trial.

1991 • 37 citations

No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.

1995 • 33 citations

Benztropine prophylaxis of dystonic reactions

1979 • 31 citations

Characterizing Anticholinergic Abuse in Community Mental Health

1989 • 31 citations

Treatment of acute neuroleptic-induced movement disorders.

1994 • 27 citations

Anaphylactic reaction after atropine

1988 • 26 citations

Risk factors for tardive dystonia: a case‐control comparison with tardive dyskinesia

1993 • 25 citations

Anticholinergic toxic psychosis in drug abusers treated with benztropine

1974 • 24 citations

The Rabbit Syndrome and Antiparkinsonian Medication in Schizophrenic Patients

1992 • 23 citations

Movement Disorder Associated with Antipsychotic Drugs: The Tardive Syndromes

1990 • 21 citations

Withdrawal symptoms after long-term treatment with low-potency neuroleptics.

1984 • 20 citations

Prophylactic Antiparkinson Drug Use: I. Initial Prophylaxis and Prevention of Extrapyramidal Side Effects

1991 • 18 citations

Serum neuroleptic and anticholinergic activity in relationship to cognitive toxicity of antiparkinsonian agents in schizophrenic patients.

1987 • 15 citations

Evaluation of the need for prophylactic antiparkinsonian medication in psychotic patients treated with neuroleptics.

1986 • 14 citations

HYSTERIA AND DRUG‐INDUCED DYSTONIA

1970 • 14 citations

Noncompliance with antiparkinsonian medications in neuroleptic-treated schizophrenic patients: three cases of an unreported phenomenon.

1994 • 3 citations

Is maintenance antiparkinsonian treatment necessary

1990 • 3 citations

Reducing Unnecessary Antiparkinson Medication in Antipsychotic Therapy

1977 • 3 citations

Assessment of Neuroleptic-Induced Extrapyramidal Symptoms

1992 • 3 citations

[Does a specific withdrawal syndrome from non-dopaminergic antiparkinson agents exist?].

1987 • 1 citations

Deleted Work

1955 • 0 citations